• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol . CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus

tetano

Editor, Senior Moderator
J Virol


. 2021 May 5;JVI.00530-21.
doi: 10.1128/JVI.00530-21. Online ahead of print.
CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus


Woojong Lee[SUP] 1 [/SUP], Brock Kingstad-Bakke[SUP] 1 [/SUP], Ross M Kedl[SUP] 2 [/SUP], Yoshihiro Kawaoka[SUP] 1 [/SUP], M Suresh[SUP] 3 [/SUP]



Affiliations

Abstract

Elicitation of lung tissue-resident memory CD8 T cells (T[SUB]RM[/SUB]s) is a goal of T-cell based vaccines against respiratory viral pathogens, such as influenza A virus (IAV). Chemokine receptor 2 (CCR2)-dependent monocyte trafficking plays an essential role in the establishment of CD8 T[SUB]RM[/SUB]s in lungs of IAV-infected mice. Here, we used a combination adjuvant-based subunit vaccine strategy that evokes multifaceted (T[SUB]C[/SUB]1/T[SUB]C[/SUB]17/T[SUB]H[/SUB]1/T[SUB]H[/SUB]17) IAV nucleoprotein-specific lung T[SUB]RM[/SUB]s, to determine whether CCR2 and monocyte infiltration are essential for vaccine-induced T[SUB]RM[/SUB] development and protective immunity to IAV in lungs. Following intranasal vaccination, neutrophils, monocytes, conventional DCs and monocyte-derived dendritic cells internalized and processed vaccine antigen in lungs. We found that Basic Leucine Zipper ATF-Like Transcription Factor 3 (BATF-3)-dependent DCs were essential for eliciting T cell responses, but CCR2 deficiency enhanced the differentiation of CD127[SUP]HI[/SUP]/KLRG-1[SUP]LO[/SUP], OX40[SUP]+ve[/SUP]CD62L[SUP]+ve[/SUP] and mucosally imprinted CD69[SUP]+ve[/SUP]CD103[SUP]+ve[/SUP] effector and memory CD8 T cells in lungs and airways of vaccinated mice. Mechanistically, increased development of lung T[SUB]RM[/SUB]s, induced by CCR2 deficiency was linked to dampened expression of T-bet, but not altered TCF-1 levels or T cell receptor signaling in CD8 T cells. T1/T17 functional programming, parenchymal localization of CD8/CD4 effector and memory T cells, recall T cell responses and protective immunity to a lethal IAV infection were unaffected in CCR2-deficient mice. Taken together, we identified a negative regulatory role for CCR2 and monocyte trafficking in mucosal imprinting and differentiation of vaccine-induced T[SUB]RM[/SUB]s. Mechanistic insights from this study may aid the development of T-cell-based vaccines against respiratory viral pathogens including IAV and SARS-CoV-2.ImportanceWhile antibody-based immunity to influenza A virus (IAV) is type and sub-type specific, lung and airway-resident memory T cells that recognize conserved epitopes in the internal viral proteins are known to provide heterosubtypic immunity. Hence, broadly protective IAV vaccines need to elicit robust T-cell memory in the respiratory tract. We have developed a combination adjuvant-based IAV nucleoprotein vaccine that elicits strong CD4 and CD8 T cell memory in lungs and protects against H1N1 and H5N1 strains of IAV. In this study, we examined the mechanisms that control vaccine-induced protective memory T cells in the respiratory tract. We found that trafficking of monocytes into lungs might limit the development of anti-viral lung-resident memory T cells, following intranasal vaccination. These findings suggested that strategies that limit monocyte infiltration can potentiate vaccine-induced frontline T-cell immunity to respiratory viruses, such as IAV and SARS-CoV-2.
 
Back
Top Bottom